Exercise trial found no clear increase in sleep duration during breast cancer chemotherapy
A small randomized trial reported less fragmented sleep and some fatigue and fitness improvements, but no increase in its primary sleep-duration outcome.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
For women with breast cancer and diagnosed insomnia, the study detected no increase in total sleep time after training. It reported less fragmented sleep and improvements in fatigue and exercise-test performance. These secondary results do not establish that the program improved insomnia overall, and the abstract leaves the size of any effects unclear.
The trial enrolled 20 women. The abstract provides no effect sizes or confidence intervals and does not specify the comparison behind the sleep-duration result, limiting assessment of possible benefit or undetected effects.
What the trial tested
Researchers made objectively measured time asleep the primary outcome. They also assessed insomnia symptoms, sleep quality, mood, fatigue, pain and exercise capacity, using sleep recordings, movement monitors, questionnaires and an exercise test.
How the outcomes differed
The reported improvements involved sleep fragmentation, physical and activity-related fatigue, and exercise-test measures. They sit alongside a different result for the primary outcome: no increase was detected in objectively measured total sleep time after training.
The original publication
Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy.
Drozd C, Curtit E, Jacquinot Q et al.
Breast Cancer Res Treat · 2026
- PubMed ID
- 41746533
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.